Results of this study demonstrate the importance of HULC and Sp transcription factors in HCC, suggesting that both HULC and Sp1 can be targeted by anticancer agents that are known to downregulate Sp transcription factors in other cancer cell lines and tumors [18, 35–40, 43]. This evidence concerns the gene HULC and hepatocellular carcinoma.